Protara Therapeutics (TARA) Short Interest Ratio & Short Volume → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free TARA Stock Alerts $4.00 +0.32 (+8.70%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Protara Therapeutics Short Interest DataCurrent Short Volume79,000 sharesPrevious Short Volume59,000 sharesChange Vs. Previous Month+33.90%Dollar Volume Sold Short$360,240.00Short Interest Ratio / Days to Cover1.1Last Record DateFebruary 29, 2024Outstanding Shares11,430,000 sharesFloat Size9,090,000 sharesShort Percent of Float0.87%Today's Trading Volume210,818 sharesAverage Trading Volume78,768 sharesToday's Volume Vs. Average268% Short Selling Protara Therapeutics ? Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTARA Short Interest Over TimeTARA Days to Cover Over TimeTARA Percentage of Float Shorted Over Time Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Protara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/202479,000 shares $360,240.00 +33.9%0.9%1.1 $4.56 2/15/202459,000 shares $208,270.00 -33.0%0.7%0.8 $3.53 1/31/202488,100 shares $224,655.00 +19.2%1.1%1.5 $2.55 1/15/202473,900 shares $170,709.00 +1.5%0.9%1.3 $2.31 12/31/202372,800 shares $136,507.28 +46.8%0.9%1.3 $1.88 12/15/202349,600 shares $88,288.00 -16.2%0.6%1.1 $1.78 Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202359,200 shares $85,840.00 +22.3%0.7%1.6 $1.45 11/15/202348,400 shares $58,080.00 +1.7%0.6%1.6 $1.20 10/31/202347,600 shares $59,271.52 -3.3%0.6%1.9 $1.25 10/15/202349,200 shares $81,180.00 -4.3%0.6%2.5 $1.65 9/30/202351,400 shares $85,838.00 +5.5%0.6%2.2 $1.67 9/15/202348,700 shares $90,095.00 -7.4%0.6%1.8 $1.85 8/31/202352,600 shares $114,668.00 +14.4%0.6%1.8 $2.18 8/15/202346,000 shares $109,020.00 -40.8%0.6%1.4 $2.37 7/31/202377,700 shares $201,243.00 -28.5%0.9%2.3 $2.59 7/15/2023108,600 shares $298,650.00 +10.0%1.3%2.9 $2.75 6/30/202398,700 shares $235,893.00 -9.0%1.2%2.7 $2.39 6/15/2023108,400 shares $308,940.00 +11.0%1.3%3.2 $2.85 5/31/202397,700 shares $272,583.00 +0.2%1.2%2.7 $2.79 5/15/202397,500 shares $328,575.00 -4.6%1.2%2.6 $3.37 4/30/2023102,200 shares $322,952.00 +34.1%1.2%3.2 $3.16 4/15/202376,200 shares $221,742.00 -0.4%0.9%2.4 $2.91 3/31/202376,500 shares $239,445.00 -0.4%0.9%3.2 $3.13 3/15/202376,800 shares $235,776.00 -0.9%0.9%3.2 $3.07 2/28/202377,500 shares $273,575.00 -5.8%0.9%4.2 $3.53 2/15/202382,300 shares $264,183.00 -2.4%0.9%4.5 $3.21 1/31/202384,300 shares $275,239.50 -0.6%1.0%3.5 $3.27 1/15/202384,800 shares $284,928.00 -1.5%1.0%3.2 $3.36 12/30/202286,100 shares $230,748.00 +8.4%1.0%3 $2.68 12/15/202279,400 shares $243,758.00 -30.8%0.9%2.5 $3.07 11/30/2022114,700 shares $404,891.00 +22.7%1.3%3 $3.53 11/15/202293,500 shares $276,760.00 +7.5%1.0%2.2 $2.96 10/31/202287,000 shares $267,090.00 +2.7%1.0%2 $3.07 10/15/202284,700 shares $281,204.00 -16.6%1.0%2.1 $3.32 9/30/2022101,600 shares $300,736.00 -9.5%1.2%2.8 $2.96 9/15/2022112,200 shares $433,092.00 +14.5%1.3%2.6 $3.86 8/31/202298,000 shares $338,100.00 +9.0%1.2%2.3 $3.45 8/15/202289,900 shares $311,953.00 -1.0%1.1%2.4 $3.47 7/31/202290,800 shares $271,492.00 -32.7%1.1%2.4 $2.99 7/15/2022135,000 shares $422,550.00 +32.1%1.6%3.6 $3.13Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now TARA Short Interest - Frequently Asked Questions What is Protara Therapeutics' current short interest? Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 79,000 shares of TARA short. 0.87% of Protara Therapeutics' shares are currently sold short. Learn More on Protara Therapeutics' current short interest. What is a good short interest ratio for Protara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 1.0. Learn More on Protara Therapeutics's short interest ratio. Which institutional investors are shorting Protara Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Protara Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Protara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.87% of Protara Therapeutics' floating shares are currently sold short. Is Protara Therapeutics' short interest increasing or decreasing? Protara Therapeutics saw a increase in short interest in February. As of February 29th, there was short interest totaling 79,000 shares, an increase of 33.9% from the previous total of 59,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Protara Therapeutics' float size? Protara Therapeutics currently has issued a total of 11,430,000 shares. Some of Protara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Protara Therapeutics currently has a public float of 9,090,000 shares. How does Protara Therapeutics' short interest compare to its competitors? 0.87% of Protara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Protara Therapeutics: IN8bio, Inc. (0.07%), Pluri Inc. (0.63%), Entera Bio Ltd. (0.00%), OKYO Pharma Limited (0.35%), Dyadic International, Inc. (0.85%), Estrella Immunopharma, Inc. (0.50%), Cyclo Therapeutics, Inc. (0.63%), Candel Therapeutics, Inc. (1.27%), Precision BioSciences, Inc. (1.46%), MiNK Therapeutics, Inc. (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Protara Therapeutics stock? Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protara Therapeutics? A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further. How often is Protara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: INAB Short Squeeze PLUR Short Squeeze ENTX Short Squeeze OKYO Short Squeeze DYAI Short Squeeze ESLA Short Squeeze CYTH Short Squeeze CADL Short Squeeze DTIL Short Squeeze INKT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company